Search

News

Announcement
- 12.06.2025

Neuraxpharm’s Corporate Values: The Principles Guiding Our Mission in CNS Care

Announcement
- 10.06.2025

Buccolam®: expanding access, empowering care in epilepsy

Announcement
- 30.05.2025

World MS Day 2025 – Amaya’s Story: The art of Moving onwardS

Announcement
- 30.04.2025

Neuraxpharm’s evolving journey in CNS innovation reflected in updated website

Announcement
- 26.03.2025

Neuraxpharm continues to shine a light on the need for improved epilepsy management

Announcement
- 04.03.2025

Reflecting on Neuraxpharm’s journey in CNS care and innovation: a video

Announcement
- 05.02.2025

Neuraxpharm appoints Vikas Mohan Sharma as Chief Medical Officer

Announcement
- 04.02.2025

Neuraxpharm Pharmaceuticals awarded EcoVadis Silver Medal for sustainability

Press release
- 10.01.2025

ZIM Laboratories Limited and Neuraxpharm Announce Grant of Marketing Authorization for “Buprenorphine Sublingual Film” in Europe

Press release
- 07.01.2025

Neuraxpharm to further grow branded business with the acquisition of two leading narcolepsy treatments, Provigil® and Nuvigil®

View more

Media Enquiries

If you are a journalist with a media enquiry, please contact the Neuraxpharm media office by filling the contact form.

CNS

Neuraxpharm

Support

Linkedin Youtube

Join our mailing list

Get the latest updates from the Neuraxpharm.